Mitochondrial iron as a potential therapeutic target in friedreich's ataxia neurodegeneration: desferioxamine-peptide conjugate

被引：0
|
作者：
Pastrana Alta, Roxana Yesenia [1 ]
Machini, Maria Teresa [1 ]
Esposito, Breno Pannia [1 ]
机构：
[1] Univ Sao Paulo, Inst Quim, Lab Peptide Chem, BR-05508 Sao Paulo, Brazil
来源：
PROTEIN SCIENCE | 2015年 / 24卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
PB-053
引用
收藏
页码：33 / 33
页数：1
相关论文
共 44 条
  • [31] Paradoxical disruption of Nrf2 signaling despite mitochondrial iron driven oxidative stress in Friedreich's ataxia cardiomyopathy
    Huang, Michael
    Anzovino, Amy
    Chiang, Shannon
    Brown, Bronwyn
    Hawkins, Clare
    Richardson, Des
    FREE RADICAL BIOLOGY AND MEDICINE, 2018, 128 : S131 - S131
  • [32] Targeting mitochondrial iron in Friedreich's ataxia skin cells protects them from ultraviolet A-induced cell death
    Reelfs, O.
    Abbate, V.
    Hider, R.
    Pourzand, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 : 41 - 41
  • [33] Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich's ataxia
    Nabhan, Joseph F.
    Wood, Kristy M.
    Rao, Varada P.
    Morin, Jeffrey
    Bhamidipaty, Surya
    LaBranche, Timothy P.
    Gooch, Renea L.
    Bozal, Fazli
    Bulawa, Christine E.
    Guild, Braydon C.
    SCIENTIFIC REPORTS, 2016, 6
  • [34] The potential of the novel NAD+ supplementing agent, SNH6, as a therapeutic strategy for the treatment of Friedreich's ataxia
    Chiang, Shannon
    Kalinowski, Danuta S.
    Dharmasivam, Mahendiran
    Braidy, Nady
    Richardson, Des R.
    Huang, Michael L. H.
    PHARMACOLOGICAL RESEARCH, 2020, 155
  • [35] Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich’s ataxia
    Joseph F. Nabhan
    Kristy M. Wood
    Varada P. Rao
    Jeffrey Morin
    Surya Bhamidipaty
    Timothy P. LaBranche
    Renea L. Gooch
    Fazli Bozal
    Christine E. Bulawa
    Braydon C. Guild
    Scientific Reports, 6
  • [36] ABAD: A Potential Therapeutic Target for Aβ-Induced Mitochondrial Dysfunction in Alzheimer's Disease
    Marques, A. T.
    Fernandes, P. A.
    Ramos, M. J.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2009, 9 (08) : 1002 - 1008
  • [37] E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia
    Benini, Monica
    Fortuni, Silvia
    Condo, Ivano
    Alfedi, Giulia
    Malisan, Florence
    Toschi, Nicola
    Serio, Dario
    Massaro, Damiano Sergio
    Arcuri, Gaetano
    Testi, Roberto
    Rufini, Alessandra
    CELL REPORTS, 2017, 18 (08): : 2007 - 2017
  • [38] Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARγ pathway as a therapeutic target in Friedreich's ataxia
    Coppola, Giovanni
    Marmolino, Daniele
    Lu, Daning
    Wang, Qing
    Cnop, Miriam
    Rai, Myriam
    Acquaviva, Fabio
    Cocozza, Sergio
    Pandolfo, Massimo
    Geschwind, Daniel H.
    HUMAN MOLECULAR GENETICS, 2009, 18 (13) : 2452 - 2461
  • [39] Potential new therapeutic target for Alzheimer's disease: Glucagon-like peptide-1
    Liu, Xiao-Yu
    Zhang, Ni
    Zhang, Sheng-Xiao
    Xu, Ping
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2021, 54 (10) : 7749 - 7769
  • [40] Cal'MAM'ity at the Endoplasmic Reticulum-Mitochondrial Interface: A Potential Therapeutic Target for Neurodegeneration and Human Immunodeficiency Virus-Associated Neurocognitive Disorders
    Proulx, Jessica
    Park, In-Woo
    Borgmann, Kathleen
    FRONTIERS IN NEUROSCIENCE, 2021, 15
12345